WASHINGTON—U.S. health advisers on Wednesday were weighing whether the overdose-reversal drug naloxone should be made available as an over-the-counter medication to help fight the national opioid crisis.
A panel of experts to the Food and Drug Administration will vote on the switch late Wednesday afternoon, following hours of presentations and discussions on whether untrained users can follow the instructions to use the antidote in emergency situations.
The brand under review, Narcan, comes as a nasal spray and is the leading version of the drug. The panel vote is a nonbinding recommendation and the FDA will make a final decision on the drug in coming weeks….
RSS Feed | The Epoch Times